Linganisha mbinu

	Dodoso la Ufahamu wa Hypoglycemia la Clarke	AGHDA: Tathmini ya Upungufu wa Homoni ya Ukuaji kwa Watu Wazima
Nyanja	Endokrinolojia	Endokrinolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	1995	2000
Mwanzilishi	William L. Clarke, Don J. Cox, Lois A. Gonder-Frederick	Anthony Hunt, Garry Werther, Peter Wrightson
Aina	Patient self-report questionnaire	Patient self-report questionnaire
Chanzo asilia	Clarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995). Reduced awareness of hypoglycemia in adults with IDDM: A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care, 18(6), 517-522.	Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346.
Majina mbadala	HAQ, Clarke HAQ, Hypoglycemia Awareness Scale	AGHDA-25
Zinazohusiana	3	3
Muhtasari	The Clarke Hypoglycemia Awareness Questionnaire is an 8-item instrument designed to identify patients with impaired hypoglycemia awareness—a condition in which diabetic patients fail to perceive early warning symptoms of low blood glucose, substantially increasing their risk of severe hypoglycemia. Developed by Clarke and colleagues in 1995, it is the most widely used screening tool for this dangerous complication in type 1 diabetes and in insulin-treated type 2 diabetes populations.	The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy.